Talaris Therapeutics, Inc. (NASDAQ:TALS) Director Suzanne Ildstad Sells 15,004 Shares

Talaris Therapeutics, Inc. (NASDAQ:TALS – Get Rating) Director Suzanne Ildstad sold 15,004 shares of the firm’s stock in a transaction that occurred on Friday, April 21st. The shares were sold at an average price of $2.35, for a total value of $35,259.40. Following the completion of the transaction, the director now directly owns 2,821,395 shares […]

Related Keywords

United States ,Suzanne Ildstad ,Morgan Stanley ,Virtu Financial ,Commonwealth Equity Services ,Jpmorgan Chase Co ,Nasdaq ,Talaris Therapeutics Company Profile ,Sg Americas Securities ,Prospera Financial Services Inc ,Talaris Therapeutics Inc ,Talaris Therapeutics ,Get Rating ,Director Suzanne Ildstad ,Therapeutics Stock Down ,Financial Services Inc ,Equity Services ,Talaris Therapeutics Daily ,Nasdaq Tals ,Metals ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,